Cancer and Metastasis Reviews

, Volume 23, Issue 3, pp 389–402

Aggressive basal cell carcinoma: Presentation, pathogenesis, and management

  • Hobart W. Walling
  • Scott W. Fosko
  • Pedram A. Geraminejad
  • Duane C. Whitaker
  • Christopher J. Arpey
Article

DOI: 10.1023/B:CANC.0000031775.04618.30

Cite this article as:
Walling, H.W., Fosko, S.W., Geraminejad, P.A. et al. Cancer Metastasis Rev (2004) 23: 389. doi:10.1023/B:CANC.0000031775.04618.30

Abstract

Basal cell carcinoma (BCC) is the most common cutaneous skin malignancy. BCC generally has a clinical course characterized by slow growth, minimal soft tissue invasiveness, and a high cure rate. Occasionally, however, BCC behaves aggressively with deep invasion, recurrence, and potential regional and distant metastasis. Several factors, including tumor size, duration, histology, and perineural spread, have been postulated as markers of the aggressive BCC phenotype. It is undetermined whether intrinsic biological factors within certain subsets of BCC predispose these tumors toward an inherently aggressive behavior, or whether any BCC with inadequate early management may assume this phenotype. Review of the pertinent literature on this topic suggests that both intrinsic biological factors and extrinsic management factors play a role in the development and progression of aggressive BCC.

cryotherapycurettageimiquimodpyrimidine dimercyclinBcl-2

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Hobart W. Walling
    • 1
  • Scott W. Fosko
    • 1
  • Pedram A. Geraminejad
    • 2
  • Duane C. Whitaker
    • 2
  • Christopher J. Arpey
    • 2
  1. 1.Department of DermatologyUniversity of Iowa Hospitals and ClinicsIowa City
  2. 2.Department of DermatologyUniversity of Iowa Hospitals and ClinicsIowa City